Filing Flows › Mimedx Group (MDXG) › Q3 2025
Mimedx Group (MDXG) Q3 2025 earnings results (third quarter 2025)
10-Q filed Oct 29, 2025
Mimedx Group (MDXG) reported revenue of $114M for the third quarter 2025 (Q3 2025), +35% from a year earlier and +15% from the quarter before. Operating margin was 19.5%, net earnings $16.7M (14.7% of revenue).
Mimedx Group, Q3 2025: revenue $114M (+35% year over year), operating margin 19.5%, net earnings $16.7M, operating cash flow $29.3M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $114M | +15% | +35% |
| Gross profit | $95.0M | +19% | +38% |
| Operating profit | $22.2M | +79% | +99% |
| Net earnings | $16.7M | +74% | +107% |
| Operating cash flow | $29.3M | +103% | +49% |
| Free cash flow | $29.1M | — | +50% |
What changed
Revenue was $113.7M in Q3 2025, up 35% year over year and up 15% from the previous quarter. Wound was the largest line at 68% of revenue. Wound added $22.0M year over year (up 40%), 74% of the total change.
Gross margin was 83.5%, up 1.8 points from a year earlier. Operating profit was $22.2M, a 19.5% margin (up 6.2 points year over year). Of the extra revenue versus a year earlier, 37% reached operating profit, above the 13% margin then. Operating expenses grew 26% against revenue growth of 35%. The fastest-growing cost line was General & admin (+30%). Net earnings were $16.7M, up 107% year over year. The effective tax rate was 26.7%.
Operating cash flow was $29.3M (up 49% year over year), 175% of net earnings. Non-cash charges added back $684K of depreciation and amortization and $4.9M of share-based compensation. Working capital and other items added $7.0M. Capital expenditures of $192K left free cash flow of $29.1M.
Questions
What was Mimedx Group's revenue in the third quarter 2025?
Mimedx Group (MDXG) reported revenue of $114M for the third quarter 2025 (Q3 2025), +35% from a year earlier and +15% from the quarter before.
Was Mimedx Group profitable in the third quarter 2025?
Operating profit was $22.2M (19.5% of revenue) and net earnings $16.7M.
Source: Mimedx Group 10-Q on SEC EDGAR.